Literature DB >> 23818204

Effect of serum containing Jinmaitong Capsule on rats' Schwann cell apoptosis induced by high glucose concentration.

Pu-Yan Wang1, Xiao-Chun Liang, Hong Zhang, Li Zhao, Qing Sun, Wen-Zhi Huang, Bo-Wu Li.   

Abstract

OBJECTIVE: To evaluate the effect of serum containing Jinmaitong Capsule (JMT) on apoptosis of Schwann cells (SCs) that are cultured in high glucose at the cellular and molecular levels.
METHODS: SCs were cultured in Dulbecco's modified Eagle's medium (control group), high glucose (50 mmol/L) medium supplemented with 20% rat serum (HG group), and 50 mmol/L glucose medium supplemented with serum containing JMT (JMT group). SC apoptosis was detected using a terminal deoxynucleotidyl transferase dUTP nick end labeling kit. The expression of Bcl-2 and the caspase-3 p20 subunit in SCs were detected by realtime fluorogenic quantitative polymerase chain reaction and confocal laser scanning microscopy, respectively.
RESULTS: No apoptosis was detected in SCs that were cultured in the control group. The percentage of apoptosis of SCs cultured in the HG group was much higher than that in the control group. The apoptosis of SCs in the JMT group was lower than that in the HG group. Fluorescence intensity of Bcl-2 and the expression of Bcl-2 mRNA in SCs that were cultured in the HG group were much lower than those in the control group and much higher than those in the JMT group (P<0.01). The fluorescence intensity of caspase-3 p20 and the expression of caspase-3 p20 mRNA in SCs that were cultured in the HG group were much higher than those in the control group (P<0.01), and they were remarkably lower in the JMT group (P<0.01).
CONCLUSIONS: JMT effectively prevents SC apoptosis that is induced by high glucose. This effect may be because of increased expression of Bcl-2 mRNA and protein and decreased expression of caspase-3 p20 mRNA and protein.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23818204     DOI: 10.1007/s11655-013-1506-7

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  12 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  The pathobiology of diabetic complications: a unifying mechanism.

Authors:  Michael Brownlee
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

Review 3.  Noninsulin-dependent diabetes mellitus as a mitochondrial genomic disease.

Authors:  C E Mathews; C D Berdanier
Journal:  Proc Soc Exp Biol Med       Date:  1998-11

4.  A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro.

Authors:  Z Han; E A Hendrickson; T A Bremner; J H Wyche
Journal:  J Biol Chem       Date:  1997-05-16       Impact factor: 5.157

5.  Mitochondrial dysfunction in neurodegenerative disorders.

Authors:  A H Schapira
Journal:  Biochim Biophys Acta       Date:  1998-08-10

6.  Distal axonopathy in streptozotocin diabetes in rats.

Authors:  S Chokroverty; D Seiden; P Navidad; R Cody
Journal:  Experientia       Date:  1988-05-15

7.  Effect of Jinmaitong serum on the proliferation of rat Schwann cells cultured in high glucose medium.

Authors:  Ling QU; Xiao-chun LIANG; Hong ZHANG; Qun-li WU; Lian-qing SUN; Bei GU
Journal:  Chin J Integr Med       Date:  2008-12-12       Impact factor: 1.978

Review 8.  Diabetic neuropathy: mechanisms to management.

Authors:  James L Edwards; Andrea M Vincent; Hsinlin T Cheng; Eva L Feldman
Journal:  Pharmacol Ther       Date:  2008-06-13       Impact factor: 12.310

9.  Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation.

Authors:  Lawrence J Coppey; Jill S Gellett; Eric P Davidson; Mark A Yorek
Journal:  Free Radic Res       Date:  2003-01

10.  Streptozocin diabetes alters immunoreactive beta-endorphin levels and pain perception after 8 wk in female rats.

Authors:  L J Forman; S Estilow; M Lewis; P Vasilenko
Journal:  Diabetes       Date:  1986-12       Impact factor: 9.461

View more
  6 in total

Review 1.  Strategies and Research Progress of Chinese Medicine in Prevention and Treatment of Diabetic Peripheral Neuropathy.

Authors:  Dan Yang; Xiao-Chun Liang
Journal:  Chin J Integr Med       Date:  2018-09-29       Impact factor: 1.978

2.  Jinmaitong decreases sciatic nerve DNA oxidative damage and apoptosis in a streptozotocin-induced diabetic rat model.

Authors:  DE-Hai Yin; Xiao-Chun Liang; L I Zhao; Hong Zhang; Qing Sun; Pu-Yan Wang; Lian-Qing Sun
Journal:  Exp Ther Med       Date:  2015-06-03       Impact factor: 2.447

3.  Jinmaitong Ameliorates Diabetic Peripheral Neuropathy Through Suppressing TXNIP/NLRP3 Inflammasome Activation In The Streptozotocin-Induced Diabetic Rat Model.

Authors:  Qing Sun; Chao Wang; Bin Yan; Xiaohu Shi; Yue Shi; Ling Qu; Xiaochun Liang
Journal:  Diabetes Metab Syndr Obes       Date:  2019-10-17       Impact factor: 3.168

4.  Combining Network Pharmacology with Experimental Validation to Elucidate the Mechanism of Salvianolic Acid B in Treating Diabetic Peripheral Neuropathy.

Authors:  Qianqian Wang; Xiaogang Li; Lijun Cao; Yan Li; Yonghui Liu; Lianqing Sun
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-27       Impact factor: 2.650

5.  A Metabolic Insight Into the Neuroprotective Effect of Jin-Mai-Tong (JMT) Decoction on Diabetic Rats With Peripheral Neuropathy Using Untargeted Metabolomics Strategy.

Authors:  Qian Zhang; Wei Song; Xiaochun Liang; Jun Xie; Yue Shi; Xiaohu Shi; Bintao Qiu; Xiuting Chen
Journal:  Front Pharmacol       Date:  2020-03-05       Impact factor: 5.810

6.  Jinmaitong ameliorates diabetic peripheral neuropathy in streptozotocin-induced diabetic rats by modulating gut microbiota and neuregulin 1.

Authors:  Jun Xie; Wei Song; Xiaochun Liang; Qian Zhang; Yue Shi; Wei Liu; Xiaohu Shi
Journal:  Aging (Albany NY)       Date:  2020-09-13       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.